CT-P39 Compared With Reference Omalizumab in Chronic Spontaneous Urticaria: Results From a Double-Blind, Randomized, Active-Controlled, Phase 3 Study.
Saini SS, Maurer M, Dytyatkovska Y, Springer E, Ratkova M, Krusheva B, Park CW, Pulka G, Chełmińska M, Reich A, Kim S, Ahn K, Kim S, Lee S, Ka J, Kim J, Grattan C.
Saini SS, et al. Among authors: park cw.
Allergy. 2025 Jan 9. doi: 10.1111/all.16446. Online ahead of print.
Allergy. 2025.
PMID: 39785096